Transcript Slide 1
What WSMOS is Doing for You Represent the best interests of oncology practitioners and patients to all cancer care stakeholders in Washington State Serve as the statewide representative of ASCO in Washington Currently: 15 Board Members representing private practice, academic centers, hospital based clinics 2 Administrative staff 290 members ◦ 248 physicians ◦ 42 affiliate members ARNP, PA, PharmD Risë Marie Cleland- WSMOS Executive Director Liz Cleland- WSMOS Associate Director Revised charter document Revised board and task force structure More sophisticated financial planning Enhanced relations with corporate sponsors Membership drive Expanded activities President Secretary/Treasurer Vincent J. Picozzi, MD, MMM Jonathan C. Britell, MD President Elect Immediate Past President Vicky E. Jones, MD Jeffery C. Ward, MD Board of Trustees Sibel Blau, MD Thomas E. Boyd, MD James Congdon, DO John Fitzharris, MD Benjamin Greer, MD Jack Keech Jr., DO Kenneth G. Kraemer, MD Matthew Lonergan, MD Richard A. McGee, MD, FACP Thomas Tucker MD Robert Witham, MD EXECUTIVE MEETINGS & EDUCATION CHAIR: President, Vince Picozzi MEMBERS: President Elect, Vicky Jones and Immediate Past President, Jeffery Ward CHAIR: Jack Keech MEMBERS: President, Vince Picozzi as exofficio, Vicky Jones TASKS: Lead the overall direction of the society, relationships with partner societies ASCO and ASH, function as nominating committee TASKS: Leadership role in development of educational meetings FINANCE CHAIR: Secretary/Treasurer, Jonathan Britell MEMBERS: President, Vince Picozzi as exofficio and Robert Witham TASKS: Assembling society budget, recommendations for revenue growth opportunities, guiding overall financial management. MEMBERSHIP CO-CHAIRS: Vicky Jones and Jeffery Ward MEMBERS: Sibel Blau, Richard McGee, Thomas Boyd, Matthew Lonergan, James Congdon, John Fitzharris, Kenneth Kraemer, TASKS: To lead membership growth efforts PAYOR PHARMACEUTICAL LIAISON CHAIR: Richard McGee MEMBERS: Matthew Lonergan and Robert Witham CHAIR: Sibel Blau MEMBERS: James Congdon and Kenneth Kraemer GOVERNMENT AFFAIRS CHAIR: Jon Britell MEMBERS: Robert Witham, Tom Boyd PATIENT ADVOCACY CHAIR: Vince Picozzi MEMBERS: Mathew Lonergan, Thomas Tucker Columbia Basin Hematology Oncology Harrison Medical Center MultiCare Regional Cancer Center North Star Lodge Northwest Medical Specialties Providence Regional Cancer Partnership Providence Western Washington Oncology Puget Sound Cancer Centers Seattle Cancer Care Alliance Swedish Cancer Institute University of Washington Virginia Mason Cancer Institute Wenatchee Valley Medical Center Diamond Members Gold Level AstraZeneca Bayer Onyx Bristol Meyers Squibb Janssen Biotech Dendreon Eisai McKesson Merck Oncology Supply/ION Seattle Genetics Spectrum Pharmaceuticals Allos Therapeutics GlaxoSmithKline Genzyme Affiliation Advocacy Scholarship Leadership www.WSMOS.org You can learn about… ◦ ◦ ◦ ◦ ◦ National oncology news Statewide oncology news/legislative updates Billing and reimbursement updates Practice resources and tools WSMOS activities and events ◦ And,……. Much, much more coming!!!!! Payors (Noridian, private sector) State Legislature ASCO CAC ASCO CPC/State Affiliate Program ASH COP Spring and Fall Meetings ( Welcome, Drs. Swain and Swisher !!!!) Seattle Blood Club Sponsorship Host organization- Best of ASH (2008) Host organization- Best of ASCO (2011) Individual Societal ◦ ASCO Grants ◦ MAC jurisdiction meeting $5,000 ASCO GRANT – APRIL 2006 OBJECTIVE: To explore the creation of a joint Washington-Alaska Medical Oncology Society. OUTCOME: WSMOS provided guidance and support in the creation of an independent Alaska State Society which is now represented in the ASCO State Affiliate program. $10,000 ASCO GRANT – APRIL 2007 OBJECTIVE: To develop a forum for ongoing regional collaboration between oncologists in AK, ID, OR and WA and the Jurisdiction 2 MAC OUTCOME: A successful regional symposium and a plan for future regional symposiums and activities that will help the state societies of Alaska, Idaho, Oregon & Washington work as one with the MAC on shared issues of concern. $10,000 ASCO GRANT – APRIL 2008 OBJECTIVE: To develop a comprehensive inventory of WA state oncology practices and their current use of midlevel providers and of their staffing profiles. OUTCOME: The publication of an Analysis of Medical Personnel Educational and Employment Opportunities in Medical Oncology. $5000 ASCO GRANT – APRIL 2010 OBJECTIVE: To create tools to be used to prepare providers for Medicare Recovery Audit Contractor (RAC) audits for both the inpatient and outpatient settings. OUTCOME: A living document providing a prototype and tools for oncologists responding to RAC audits. AGENDA May 11, 2012 7:45-8:30am Cedarbrook Lodge, SeaTac Breakfast with Exhibitors 8:30-9:15am Welcome & Introductions - What WSMOS Is Doing For You & Hazardous Drug Bill Update Vince Picozzi, MD, MMM President, Jon Britell, MD Risë Cleland, WSMOS 9:15-10:15am ASCO & You Sandra Swain, MD ASCO, Jeffery Ward, MD, WSMOS 10:15-10:30am 10:30-11:45pm 11:45-12:45pm Break with Exhibitors Best of San Antonio Breast Conference – HER 2 Pathways Sandra Swain, MD Lunch with Exhibitors 12:45-1:45pm Preparing for ICD-10 Michelle Lott, CPC & Bob Perna, WSMA 1:45pm-2:45pm Ovarian Translational Research Liz Swisher, MD 2:45-3:45pm Coping with Drug Shortages – Panel Discussion Jeff Ward, MD, Annie Lambert, PharmD, MultiCare Regional Cancer Center, Renee Curtis, PharmD, Everett Clinic Medicare Refunds and Reporting Overpayments David Glaser, JD, Fredrickson and Byron 3:45- 4:30pm 4:30-6:00pm Networking Cocktail Reception Diamond Member Recognition Your Washington State Medical Oncology Society A Unified Community of Oncology Professionals Promoting the Highest Professional Standards of Oncology Practice NAVIGATING NIOSH WSMOS AT WORK FOR YOU Jonathan C. Britell MD May 11, 2012 Mandated that the Department of Labor and Industries adopt rules “consistent with but no more stringent than guidelines of National Institute for Occupational Safety and Health (NIOSH) regarding handling of chemotherapy hazardous drugs.” First in the Nation ◦ Stakeholder meetings: ◦ June 15, 2011 August 31, 2011 ◦ Public Hearing on Rules: November 28, 2011 December 7, 2011 ◦ Rules Published: January 3, 2012 ◦ Advisory Committee: Meetings ◦ January 24, 2012 March 26, 2012 May 7, 2012 Original Proposed Rule Scope: any exposure Coverage: Physicians, PAs, ARNPs, RNs, LPNs, nurses aids Patient care assistive personnel, Pharmacists, Pharmacy techs, Environmental services, Shipping and handling Original Actual Rule When exposure reasonably anticipated based on type of drug Coverage: Same except for nurses aids excluded Finalized Hazardous Drug Control Program In place July 1, 2012 Contents: Inventory and hazard assessment of drugs, Policies and Procedures for Handling Engineering Controls Personal Protective Equipment Safe Handling Cleaning, housekeeping Spill Control MEDICAL SURVEILLANCE Personnel issues (pregnancy) Training Record Keeping Original Hazardous Drug Control Program Delayed ‘til Jan 1, 2014 Medical Surveillance deferred Record keeping minimized Finalized Personal Protective Equipment Double gloving during compounding, administering, or handling contaminated fluids, linens Original Personal Protective Equipment Double glove during compounding, and cleaning up large spills Finalized Personal Protective Equipment Change gloves every 30 minutes or when torn, punctured or contaminated Gowns: polyethylene coated polypropylene Original Personal Protective Equipment Change gloves every 30 to 60 minutes or when torn, punctured or contaminated Gowns: polyethylene coated polypropylene or other “non absorbent, non-linting material Finalized Engineering Controls Biologic safety cabinets Containment isolators Closed system devices Safer Sharps devices Safety Interlocks Original Engineering Controls Closed system devices Safer Sharps devices Safety Interlocks Ventilated Cabinets Finalized Medical Surveillance Anyone who handles drugs or patient waste within 48 hours of administration On hire, following exposure, regular schedule and at termination Questionnaire, exam, lab, maintain records 10 years minimum Original Medical Surveillance All on hold until NIOSH can make sense of the science behind this and come up with reasonable rules Finalized Record Keeping Training: Dates, Content, Name and title Medical Exposure Spill Records Original Record Keeping “Inform and train your employees about hazardous chemicals in your workplace.” Finalized Implementation July 1, 2012 Original Implementation Hazardous Drugs Control Program – Jan 1, 2014 Employee Training July 1, 2014 Installation of Ventilated Hoods Jan 1, 2015 Finalized L&I Advisory Board Role: To review a) new NIOSH recommendations b) new scientific/tech developments c) Unanticipated implementation issues d) Provide advisory recommendations to L&I L&I Advisory Board Make up: 5 Business Representatives 5 Labor Representatives 1 Non-voting Dept of Health Rep L&I Advisory Board Representatives will be chosen from: Outpatient Community Practices Community/Compounding Pharmacies Hospitals and Large Healthcare Organizations Nursing Homes/Long term care Veterinary Practices State Agencies that are health care employers Practices/Hospitals/Pharmacies Physical plant modification Develop Hazardous Drug Control Plan L&I and all stakeholders: Develop Best Practices Repository Share Them We shouldn’t have to reinvent the wheel Links: http://www.lni.wa.gov/Safety/Topics/AtoZ/HazardousDrugs/ For latest updates on rules and further links to the rules themselves